Stock Events

Stock Events

Sirona Biochem 

€0.04
14
-€0-8.86% Thursday 07:04

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
9.32M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29SepExpected
Q2 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0012

Financials

-7,365.94%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
47,061.71Revenue
-3.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZSB.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
L`Oreal
LRLCY
Mkt Cap227.49B
L'Oréal operates in the beauty and skincare sector, directly competing with Sirona Biochem's cosmetic ingredient development.
Estee Lauder Cos.
EL
Mkt Cap34.84B
Estée Lauder competes in the development and marketing of skincare, makeup, fragrance, and hair care products, similar to Sirona's focus areas.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its consumer health division, competes in the skincare market, particularly in the development of beauty and personal care products.
Procter & Gamble
PG
Mkt Cap351.37B
Procter & Gamble competes across various segments including skincare and personal care, overlapping with Sirona Biochem's market.
Unitedhealth Group
UNH
Mkt Cap309.4B
Unilever, with its vast portfolio of personal care and beauty brands, competes in the same market as Sirona Biochem.
Colgate-Palmolive
CL
Mkt Cap62.27B
Colgate-Palmolive, through its personal care products, competes in the oral and skin care markets, relevant to Sirona's interests.
Kimberly-Clark
KMB
Mkt Cap39.73B
Kimberly-Clark, with products in the personal care segment, competes indirectly by offering skincare products.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline, through its consumer healthcare division, competes in the oral health and nutritional products market, indirectly competing with Sirona.
Novartis
NVS
Mkt Cap237.61B
Novartis, a pharmaceutical company, competes indirectly through its dermatology division, focusing on skin conditions that could overlap with Sirona's cosmetic ingredient innovations.

About

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Show more...
CEO
Dr. Howard J. Verrico M.D., Ph.D.
Country
CA
ISIN
CA82967M1005
WKN
000A0RM6R

Listings

OTC Link
US
SRBCF
F
DE
ZSB.F

0 Comments

Share your thoughts

FAQ

What is Sirona Biochem stock price today?▼
The current price of ZSB.F is €0.04 EUR — it has decreased by -8.86% in the past 24 hours. Watch Sirona Biochem stock price performance more closely on the chart.
What is Sirona Biochem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sirona Biochem stocks are traded under the ticker ZSB.F.
What is Sirona Biochem market cap?▼
Today Sirona Biochem has the market capitalization of 9.32M
What is Sirona Biochem revenue for the last year?▼
Sirona Biochem revenue for the last year amounts to 47,061.71 EUR.
What is Sirona Biochem net income for the last year?▼
ZSB.F net income for the last year is -3.47M EUR.
In which sector is Sirona Biochem located?▼
Sirona Biochem operates in the Health Care sector.
When did Sirona Biochem complete a stock split?▼
Sirona Biochem has not had any recent stock splits.
Where is Sirona Biochem headquartered?▼
Sirona Biochem is headquartered in Vancouver, CA.